Study for people with Liver Cancer

Recruiting Not a phased study

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Not a phased study
Sponsor Maastricht University
Registry number NCT06914648
Started 1 April 2025 Today 16 October 2026 Estimated completion 15 November 2032

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Monash Medical Center Melbourne Australia Not yet recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years and over
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 358

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* PLC diagnosis, specifically iCCC, pCCC, and HCC;

* Requiring PVE due to an FLR volume is \<30% in normally functioning livers, \<40% in livers with potentially impaired function e.g. resulting from prior systemic therapy induction or bile duct colonization / transpapillary biliary drainage, or \<50% in livers with severely impaired function resulting from liver cirrhosis (max. Child Pugh A5) OR function on hepatobiliary scintigraphy (HEBIS) is \< 2.7 %/min/m2;

* Age ≥ 18 years;

* Able to understand the trial and provide informed consent.

Exclusion Criteria:

* Liver cirrhosis with a Child-Pugh score of B or C;

* Presence of portal hypertension;

* Presence of cholangitis;

* Pregnant women;

* Premenopausal females not able/willing to commit to contraception (specifically long-acting reversible contraception or hormonal contraception);

* Patients unresectable due to prohibitive comorbidities (decision made by local multidisciplinary team);

* Patients with hepatic malignancies other than iCCC, pCCC or HCC;

* PVE/HVE anatomically not feasible;

* Any patient with non-resectable or non-ablatable extrahepatic metastatic disease.

* Unable to understand the study information, study instructions and give informed consent

Dates on the record

Started 1 April 2025
Estimated completion 15 November 2032
Registry last updated 15 May 2025
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 15 May 2025.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.